The user facility reported to terumo cardiovascular that prior to cardiopulmonary bypass, during setup, there was leaking manifold connection off of the side of the outflow of the oxygenator.No patient involvement.The product was changed out.The surgery was completed successfully.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on apr 6, 2022.Upon further investigation of the reported event, the following information is new and/or changed: h6 (identification of evaluation codes 11, 3331, 4114, 4210, 4307) type of investigation #1: 11 - testing of device from same lot/batch retained by manufacturer.Type of investigation #2: 3331 - analysis of production records.Type of investigation #3: 4114 - device not returned.Investigation finding: 4210 - leakage/seal.Investigation conclusions: 4307 - cause traced to component failure.The affected sample was not returned.However, a video was provided showing a leak at the arterial pigtail port which confirms this event.A representative retention sample was inspected to confirm no visual damage or anomalies with the arterial pigtail.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|